MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis
National Institute of Diabetes and Digestive and Kidney Diseases · National Institutes of Health · +16 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
705
total citations
- FWCI
- 46.32
- Percentile
- 100%
- References
- 52
Citations per year
Authors
23- JBJeffrey B. KoppCorresponding
National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health
- MWMichael W. Smith
Science Applications International Corporation (United States), National Cancer Institute
- GWGeorge W. Nelson
National Cancer Institute, Science Applications International Corporation (United States)
- RCRandall C. Johnson
National Cancer Institute, Science Applications International Corporation (United States)
- BIBarry I. Freedman
Wake Forest University
Topics & keywords
Topics
Keywords
- Focal segmental glomerulosclerosis
- Linkage disequilibrium
- Biology
- Kidney disease
- Haplotype
- Single-nucleotide polymorphism
- Locus (genetics)
- Genetics
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.